needs a CT or not-which of these three high quality rules should I follow? We answered this question by assessing the ability of these rules to predict positive cases of clinically important brain injury, although the PECARN rule was not designed to do so. 2 We acknowledge the limitations of the analysis, but believe that it provides important information for clinicians.
Kuppermann and colleagues point out that the PECARN, CATCH, and CHALICE rules preceded the commencement of our study, which might have led to lowered CT rates. This is possible. However, a survey 3 preceding our study indicated that the rules were not commonly used by senior staff and were not incorporated into local clinical practice guidelines. Furthermore, a retrospective database audit 4 of head injuries between 2001 and 2010 in Australian hospitals has shown consistently low CT rates of about 10% for children with head injuries preceding the publication of the rules. We agree that the low CT rate reported in our study might be partly due to the inclusion of patients with mild head injuries, who were excluded in the PECARN study. 2 As highlighted by Kuppermann and colleagues, the rate of hospital admissions in our study was higher than in the PECARN study and likely highlights the trade-off between CT and observation or hospital admission. Of note, our data describe admissions to a ward rather than prolonged obser vation in general.
Kuppermann and colleagues also respond to the accompanying Lancet Comment 5 by William R Mower, which suggested that the strict application of the PECARN rule as an imaging decision tool in children could result in CT rates of nearly 50%. This is not what we reported in our study. 4 We emphasised the point that a projected CT rate for PECARN cannot be established because nonlow risk patients can either have a CT scan or be observed. of 9-17%, similar to the CT rate reported by Babl and colleagues, with no missed neurosurgical injuries. [4] [5] [6] Neuroimaging prediction rules for children with head trauma should empower clinical judgment rather than replace it.
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